亚太药业6月30日股东户数5.51万户，较上期减少9.36%

Core Viewpoint - Asia-Pacific Pharmaceutical disclosed a decrease in shareholder accounts and an increase in average shareholding quantity, indicating a shift in investor behavior despite a positive stock price performance during the reporting period [1][2]. Group 1: Shareholder Statistics - As of June 30, 2025, the number of shareholders for Asia-Pacific Pharmaceutical was 55,101, a decrease of 5,691 accounts, representing a reduction of 9.36% compared to March 31, 2025 [1][2]. - The average number of shares held per account increased from 12,200 shares to 13,500 shares, while the average market value of shares held per account was 51,400 yuan [1][2]. - The average number of shareholders in the chemical pharmaceutical industry was 32,900, indicating that Asia-Pacific Pharmaceutical's shareholder count is above the industry average [1]. Group 2: Stock Performance - From March 31, 2025, to June 30, 2025, Asia-Pacific Pharmaceutical's stock price increased by 14.11%, despite the reduction in shareholder accounts [1][2]. - During the same period, the company experienced a net inflow of 141 million yuan from institutional investors, while retail investors saw a net outflow of 56.45 million yuan [2].